Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2025-09-19 00:00:00 ET · period of report 2025-09-17 · accession 0001193125-25-209353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2025-09-17 | CRSP | Kulkarni Samarth | CEO, Dir | G - Gift | $0.00 | -6,000 | 201.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-09-17 | G | D | 6,000 | $0.00 | 201,004 | D | — | — | (F1) The reporting person made a charitable contribution of common shares to a donor advised fund. |